Inpatient Asthma Care and Future Morbidity: A Role for Quality Improvement

Children with asthma continue to suffer significant morbidity¹ despite improved treatment options and widely distributed best practice guidelines.² The best predictor of future severe asthma exacerbations is a recent asthma exacerbation.^3,4 In “Inpatient Quality Improvement Interventions for Asthma: A Meta-analysis” published this month in Pediatrics, Parikh et al⁵ examine the impact of quality improvement (QI) initiatives conducted during inpatient asthma hospitalization on future (postdischarge) asthma morbidity. After reviewing an array of inpatient asthma interventions, they used meta-analysis to conclude that inpatient QI efforts have limited impact on postdischarge asthma outcomes. Their findings reveal the paucity of programs directed at improving postdischarge asthma control. Importantly, they identify some positive outcomes after inpatient multimodal targeted asthma QI interventions.

We applaud Parikh et al⁵ for conducting this ambitious analysis, especially given the wide range of interventions, methodologies, measured outcomes, and disparate care settings wherein asthma inpatient QI was conducted. We also congratulate them for evaluating whether inpatient QI work alone has short- or long-term effects on future asthma morbidity (ie, asthma-related emergency department [ED] revisits or readmissions). We suspect some think it naïve to believe inpatient QI work alone can impact future asthma morbidity; however, until an analysis was conducted, this could only be conjecture. The analysis by Parikh et al⁵ seems to codify the conclusion that inpatient QI work, as currently practiced, has limited impact on future asthma morbidity.

The authors’ methods were thorough. They focused primarily on postdischarge asthma ED revisits and hospital readmissions as outcomes common to the majority of articles reviewed. They eliminated 18 articles from study because prevention of revisits and/or readmissions was not an intervention goal. Among the eliminated articles, revisits and/or readmissions were frequently balancing measures used to monitor whether hospital length of stay or cost reductions increased postdischarge morbidity.

In the 12 articles used for the meta-analysis, the authors described strategies ranging from primarily asthma education^6,7 to multicomponent interventions targeting compliance with the Joint Commission Children’s Asthma Care measures.⁸ Although the authors state that these studies were used to target the outcome of posthospital use, closer review reveals that 1 study was focused on developing “a cost saving algorithm,”⁹ whereas another study’s goal was to improve general practitioner “satisfaction with communication provided by the hospital.”¹⁰ Implementation strategies varied from randomized controlled trials of standardized interventions to interventions that evolved during plan-do-study-act cycles. The methodology for identifying index hospitalizations along with postintervention study intervals varied.

The resulting nonhomogeneity of the studies makes Parikh’s et al⁵ meta-analysis of overall inpatient asthma QI efficacy inconclusive. However, their article does reveal several important issues. Inpatient asthma QI has not been aggressively aimed at improving postdischarge asthma morbidity. Instead, QI efforts are often centered on reducing inpatient length of stay and costs. With this focus, researchers fail to address these vulnerable patients’ increased risk for future asthma exacerbations or take advantage of a severe asthma episode’s wake-up call to trigger change in provider and caregiver management.¹¹

Parikh et al⁵ point out that unidimensional inpatient interventions have little impact on subsequent asthma-related health care use. This is particularly true for projects that are focused primarily on education. Unfortunately, education alone is usually insufficient to change caregiver home management.¹² This is also true for providers; simply providing instruction regarding asthma guideline care does not guarantee practice change.¹³

The multifaceted programs reviewed by the authors had more impact. Programs that combined education with dispensing emergency oral steroid supplies or confirmed medical home follow-up improved outcomes. Inpatient care standardization that included assessment of the patient’s past clinical asthma control followed by adjustment and prescription of controller medication (especially if those medications were “in hand” at discharge) was effective. Programs employing a standard QI and multidimensional care improvement strategy^8,14–16 were especially consistent in their ability to reduce ED revisits and/or rehospitalizations. The lack of impact by a multidimensional QI-based program for a group of community hospitals¹⁷ was confounded by the small baseline numbers of readmissions. Asthma readmissions may be an insensitive outcome measure for smaller patient populations. In addition, this measure fails to fully assess the more global impact asthma has on quality of life.

The time has come to focus on asthma hospitalizations as opportunities to address ongoing asthma control for patients at high risk for future asthma morbidity. We must address the continuum of asthma care from inpatient to outpatient and home care. We should abandon unidimensional approaches and instead focus on multifaceted “bundles” of interventions. We must address both provider and caregiver contributions to asthma morbidity.^15,18,19 Outcome measures should identify not only severe attacks but also the less calamitous and more common ways asthma is detrimental to our patients and their families.²⁰ Finally, we believe using a standard and rigorous QI approach with multidimensional targets and tactics is more likely to get results. This approach has been effective in driving change,¹⁴ allows for fluid adjustment in interventions to speed impact, and does not leave a portion of children behind to receive “usual care.”

• Copyright © 2018 by the American Academy of Pediatrics